RE: valuation?21 Jun 2020 09:40
Ridiculous talking of £50 per share, absolute pie in the sky valuations by dreamers. That would give us a market cap of
£11 Billion, the same value as Britain’s biggest Pharmaceutical company AstraZenica. However I think £5 per share is possible short term and £10 a share in the medium term if the profits stack up. It is possible that we might get taken over at £15 per share but that’s as far as it goes as more competitors enter the market.